ALDH1A2 and ovarian carcinoma: To elucidate the clinical significance of ALDH1A2 in ovarian cancer patients, we compared ALDH1A2 expression levels by immunohistochemistry in benign, borderline, and malignant ovarian tumor tissues and in normal ovarian/fallopian epithelial tissues (Figure 6A).